Biotech StocksInsights Healthcare Analysts Weigh In on Two Biotech Stocks: MannKind Corporation (MNKD), Amarin Corporation plc (ADR) (AMRN) MannKind Corporation Piper Jaffray analyst Joshua Schimmer weighed in on shares of MannKind Corporation (NASDAQ:MNKD) after the company’s founder passed away today at the age … Jason Cohen, February 26, 2016
Biotech StocksStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Fourth Quarter and Year-End 2015 Financial Resultsand Provides Update on Operations Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the … Corey Williams, February 25, 2016
Biotech StocksStock News Amarin Corporation plc (ADR): Request for Continued Stay in Court Proceedings Submitted in Amarin First Amendment Litigation Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that parties to the Amarin First Amendment litigation have jointly requested a continued stay in court proceedings. Following the … Corey Williams, February 17, 2016
Biotech StocksStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Appoints Craig B. Granowitz Chief Medical Officer and Names Steven Ketchum Chief Scientific Officer Amarin Corporation plc (ADR) (NASDAQ:AMRN) has appointed Craig B. Granowitz, M. Corey Williams, January 21, 2016
Biotech StocksStock News Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Agreement to Purchase $16.2 Million of Its Existing Exchangeable Notes and Pricing of $31.3 Million of New Exchangeable Notes Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that it and its wholly owned subsidiary, Corsicanto Limited, a private limited company incorporated under the laws of … Corey Williams, November 20, 2015
Biotech StocksStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Shines Light on CHERRY study Amarin Corporation plc (ADR) (NASDAQ:AMRN) commented on new data from the CHERRY study that supports the hypothesis under investigation in Amarin’s cardiovascular outcomes study … Corey Williams, November 9, 2015
Biotech StocksStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Reports Third Quarter 2015 Financial Results and Provides Update on Operations Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results … Corey Williams, November 4, 2015
Biotech StocksStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Encore Presentation at the European Society of Cardiology (ESC) 2015 Annual Congress Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced the encore presentation of findings from a post-hoc analysis examining the effects of icosapent ethyl (Vascepa®) on Apolipoprotein … Corey Williams, August 27, 2015
Biotech StocksStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Promotes Joseph T. Kennedy to Executive Vice President, General Counsel and Strategic Initiatives Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today the promotion … Corey Williams, August 11, 2015
Biotech StocksInsightsTop-Rated Analysts Oppenheimer Weighs in on Amarin Corporation plc (ADR) Following 2Q:15 Results Oppenheimer analyst Akiva Felt weighed in with a few insights on Amarin Corporation plc (ADR)(NASDAQ:AMRN), after the pharmaceutical company released its second-quarter results last week. … Jason Cohen, August 10, 2015
